Biktarvy Prices, Coupons, Copay Cards & Patient Assistance
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
Biktarvy is available as a brand name drug only, a generic version is not yet available. View generic Biktarvy availability for more details.
Biktarvy prices
Oral Tablet
30 mg-120 mg-15 mg Biktarvy oral tablet from $4,126.19 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $137.54 | $4,126.19 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
50 mg-200 mg-25 mg Biktarvy oral tablet from $4,126.19 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $137.54 | $4,126.19 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Biktarvy Coupons, Copay Cards and Rebates
Biktarvy offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Biktarvy Gilead Advancing Access Co-pay Savings Program
Eligible commercially insured patients may save up to $7200 per calendar year with no monthly limit.
- Applies to:
- Biktarvy
- Number of uses:
- per prescription per year
Form more information phone: 800-226-2056 or Visit website
Biktarvy Direct Member Reimbursement
Commercially insured patients already enrolled in the copay savings program may be eligible for direct reimbursement if out-of-pocket payment was made.
- Applies to:
- Biktarvy
- Number of uses:
- One rebate per prescription fill
Form more information phone: 800-226-2056 or Visit website
Patient Assistance & Copay Programs for Biktarvy
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Advancing Access Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- This program is for outpatient use only. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. *IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
- Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet
More information please phone: 800-226-2056 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet
More information please phone: 866-316-7263 Visit website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Biktarvy (bictegravir-emtricitabine-tenofovir alafenamide) Tablet
More information please phone: 877-968-7233 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Reviews (226)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
- Biktarvy prescribing information
- Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate (AHFS Monograph)